{"count": 19, "results": [{"_id": "34116042", "pmid": 34116042, "title": "Effect of anti-hyperglycemic drugs on endoplasmic reticulum (ER) stress in human coronary artery endothelial cells.", "journal": "Eur J Pharmacol", "authors": ["Kapadia P", "Bikkina P", "Landicho MA", "Parekh S", "Haas MJ", "Mooradian AD"], "date": "2021-09-15T00:00:00Z", "doi": "10.1016/j.ejphar.2021.174249", "meta_date_publication": "2021 Sep 15", "meta_volume": "907", "meta_issue": "", "meta_pages": "174249", "score": 50258.95, "text_hl": "Seven classes of anti-@<m>DISEASE_Ototoxicity</m> @DISEASE_MESH:D000081015 @@@hyperglycemic drugs@@@ were screened including @CHEMICAL_Sulfonylurea_Compounds @CHEMICAL_MESH:D013453 @@@sulfonylureas@@@, @CHEMICAL_meglitinide @CHEMICAL_MESH:C030516 @@@meglitinides@@@, @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@, alpha glucosidase inhibitors, @CHEMICAL_2_4_thiazolidinedione @CHEMICAL_MESH:C089946 @@@thiazolidinedione@@@, @GENE_GLP1R @GENE_2740 @@@glucagon like peptide 1 (GLP-1) receptor@@@ agonists and @GENE_SLC5A2 @GENE_6524 @@@sodium-glucose cotransporter 2@@@ (@GENE_SLC5A2 @GENE_6524 @@@SGLT-2@@@) inhibitors. ", "citations": {"NLM": "Kapadia P, Bikkina P, Landicho MA, Parekh S, Haas MJ, Mooradian AD. Effect of anti-hyperglycemic drugs on endoplasmic reticulum (ER) stress in human coronary artery endothelial cells. Eur J Pharmacol. 2021 Sep 15;907():174249. PMID: 34116042", "BibTeX": "@article{34116042, title={Effect of anti-hyperglycemic drugs on endoplasmic reticulum (ER) stress in human coronary artery endothelial cells.}, author={Kapadia P and Bikkina P and Landicho MA and Parekh S and Haas MJ and Mooradian AD}, journal={Eur J Pharmacol}, volume={907}, pages={174249}}"}}, {"_id": "36579709", "pmid": 36579709, "title": "Identification of polypharmacy patterns in new-users of metformin using the Apriori algorithm: A novel framework for investigating concomitant drug utilization through association rule mining.", "journal": "Pharmacoepidemiol Drug Saf", "authors": ["Faquetti ML", "la Torre AM", "Burkard T", "Obozinski G", "Burden AM"], "date": "2022-12-29T00:00:00Z", "doi": "10.1002/pds.5583", "meta_date_publication": "2022 Dec 29", "meta_volume": "", "meta_issue": "", "meta_pages": "", "score": 50258.05, "text_hl": "Identification of polypharmacy patterns in new-users of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ using the Apriori algorithm: A novel framework for investigating concomitant @<m>DISEASE_Ototoxicity</m> @DISEASE_MESH:D000081015 @@@drug@@@ utilization through association rule mining.", "citations": {"NLM": "Faquetti ML, la Torre AM, Burkard T, Obozinski G, Burden AM. Identification of polypharmacy patterns in new-users of metformin using the Apriori algorithm: A novel framework for investigating concomitant drug utilization through association rule mining. Pharmacoepidemiol Drug Saf. 2022 Dec 29;():. PMID: 36579709", "BibTeX": "@article{36579709, title={Identification of polypharmacy patterns in new-users of metformin using the Apriori algorithm: A novel framework for investigating concomitant drug utilization through association rule mining.}, author={Faquetti ML and la Torre AM and Burkard T and Obozinski G and Burden AM}, journal={Pharmacoepidemiol Drug Saf}}"}}, {"_id": "38192642", "pmid": 38192642, "pmcid": "PMC10773879", "title": "Metformin: update on mechanisms of action on liver diseases", "journal": "Front Nutr", "authors": ["Ruan G", "Wu F", "Shi D", "Sun H", "Wang F", "Xu C"], "date": "2023-12-14T00:00:00Z", "doi": "10.3389/fnut.2023.1327814", "meta_date_publication": "2023", "meta_volume": "10", "meta_issue": "", "meta_pages": "1327814", "score": 50257.855, "text_hl": "Moreover, @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ protects against chemical-induced and @DISEASE_Chemical_and_Drug_Induced_Liver_Injury @DISEASE_MESH:D056486 @@@drug-induced liver injury@@@ (@DISEASE_Chemical_and_Drug_Induced_Liver_Injury @DISEASE_MESH:D056486 @@@DILI@@@) against @<m>DISEASE_Ototoxicity</m> @DISEASE_MESH:D000081015 @@@hepatotoxic drugs@@@. ", "citations": {"NLM": "Ruan G, Wu F, Shi D, Sun H, Wang F, Xu C. Metformin: update on mechanisms of action on liver diseases Front Nutr. 2023;10():1327814. PMID: 38192642", "BibTeX": "@article{38192642, title={Metformin: update on mechanisms of action on liver diseases}, author={Ruan G and Wu F and Shi D and Sun H and Wang F and Xu C}, journal={Front Nutr}, volume={10}, pages={1327814}}"}}, {"_id": "31689532", "pmid": 31689532, "title": "Metformin promotes Mycobacterium tuberculosis killing and increases the production of human beta-defensins in lung epithelial cells and macrophages.", "journal": "Microbes Infect", "authors": ["Rodriguez-Carlos A", "Valdez-Miramontes C", "Marin-Luevano P", "González-Curiel I", "Enciso-Moreno JA", "Rivas-Santiago B"], "date": "2020-04-01T00:00:00Z", "doi": "10.1016/j.micinf.2019.10.002", "meta_date_publication": "2020 Apr", "meta_volume": "22", "meta_issue": "3", "meta_pages": "111-118", "score": 50249.266, "text_hl": "In the present study, we aimed to determine the role of anti-@<m>DISEASE_Ototoxicity</m> @DISEASE_MESH:D000081015 @@@hyperglycemic drugs@@@ such as @CHEMICAL_Glyburide @CHEMICAL_MESH:D005905 @@@glyburide@@@, @GENE_INS @GENE_3630 @@@insulin@@@, and @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ to promote the killing of mycobacteria through the regulation of innate immune molecules such as host defense peptides (HDP) in lung epithelial cells and macrophages. ", "citations": {"NLM": "Rodriguez-Carlos A, Valdez-Miramontes C, Marin-Luevano P, González-Curiel I, Enciso-Moreno JA, Rivas-Santiago B. Metformin promotes Mycobacterium tuberculosis killing and increases the production of human beta-defensins in lung epithelial cells and macrophages. Microbes Infect. 2020 Apr;22(3):111-118. PMID: 31689532", "BibTeX": "@article{31689532, title={Metformin promotes Mycobacterium tuberculosis killing and increases the production of human beta-defensins in lung epithelial cells and macrophages.}, author={Rodriguez-Carlos A and Valdez-Miramontes C and Marin-Luevano P and González-Curiel I and Enciso-Moreno JA and Rivas-Santiago B}, journal={Microbes Infect}, volume={22}, number={3}, pages={111-118}}"}}, {"_id": "37549729", "pmid": 37549729, "title": "Metformin alleviates glucolipotoxicity-induced pancreatic beta cell ferroptosis through regulation of the GPX4/ACSL4 axis.", "journal": "Eur J Pharmacol", "authors": ["Sun Y", "Guo LQ", "Wang DG", "Xing YJ", "Bai YP", "Zhang T", "Wang W", "Zhou SM", "Yao XM", "Cheng JH", "Chang WW", "Lv K", "Li CX", "Kong X"], "date": "2023-08-05T00:00:00Z", "doi": "10.1016/j.ejphar.2023.175967", "meta_date_publication": "2023 Aug 5", "meta_volume": "", "meta_issue": "", "meta_pages": "175967", "score": 50247.56, "text_hl": "However, the role of glucolipotoxicity in inducing beta cell ferroptosis remains unclear. @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ (@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Met@@@), @CHEMICAL_Exenatide @CHEMICAL_MESH:D000077270 @@@exenatide@@@ (@CHEMICAL_Exenatide @CHEMICAL_MESH:D000077270 @@@Exe@@@), and @CHEMICAL_saxagliptin @CHEMICAL_MESH:C502994 @@@saxagliptin@@@ (@CHEMICAL_saxagliptin @CHEMICAL_MESH:C502994 @@@Sax@@@) are frequently used @<m>DISEASE_Ototoxicity</m> @DISEASE_MESH:D000081015 @@@anti-hyperglycaemic drugs@@@. ", "citations": {"NLM": "Sun Y, Guo LQ, Wang DG, Xing YJ, Bai YP, Zhang T, Wang W, Zhou SM, Yao XM, Cheng JH, Chang WW, Lv K, Li CX, Kong X. Metformin alleviates glucolipotoxicity-induced pancreatic beta cell ferroptosis through regulation of the GPX4/ACSL4 axis. Eur J Pharmacol. 2023 Aug 5;():175967. PMID: 37549729", "BibTeX": "@article{37549729, title={Metformin alleviates glucolipotoxicity-induced pancreatic beta cell ferroptosis through regulation of the GPX4/ACSL4 axis.}, author={Sun Y and Guo LQ and Wang DG and Xing YJ and Bai YP and Zhang T and Wang W and Zhou SM and Yao XM and Cheng JH and Chang WW and Lv K and Li CX and Kong X}, journal={Eur J Pharmacol}, pages={175967}}"}}, {"_id": "40978121", "pmid": 40978121, "title": "Sodium-glucose co-transporter-2 inhibitors vs metformin in reducing osteoarthritis risk: a retrospective cohort study of health insurance claims and check-up data.", "journal": "JBMR Plus", "authors": ["Hatano M", "Sasabuchi Y", "Okada A", "Ishikura H", "Tanaka T", "Saito T", "Tanaka S", "Yasunaga H"], "date": "2025-08-12T00:00:00Z", "doi": "10.1093/jbmrpl/ziaf132", "meta_date_publication": "2025 Oct", "meta_volume": "9", "meta_issue": "10", "meta_pages": "ziaf132", "score": 50245.113, "text_hl": "We aimed to compare the incidence of @DISEASE_Osteoarthritis @DISEASE_MESH:D010003 @@@osteoarthritis@@@ between individuals receiving @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@, the most common anti-@<m>DISEASE_Ototoxicity</m> @DISEASE_MESH:D000081015 @@@hyperglycemic drug@@@, and sodium-glucose co-transporter-2 inhibitors (SGLT-2is). ", "citations": {"NLM": "Hatano M, Sasabuchi Y, Okada A, Ishikura H, Tanaka T, Saito T, Tanaka S, Yasunaga H. Sodium-glucose co-transporter-2 inhibitors vs metformin in reducing osteoarthritis risk: a retrospective cohort study of health insurance claims and check-up data. JBMR Plus. 2025 Oct;9(10):ziaf132. PMID: 40978121", "BibTeX": "@article{40978121, title={Sodium-glucose co-transporter-2 inhibitors vs metformin in reducing osteoarthritis risk: a retrospective cohort study of health insurance claims and check-up data.}, author={Hatano M and Sasabuchi Y and Okada A and Ishikura H and Tanaka T and Saito T and Tanaka S and Yasunaga H}, journal={JBMR Plus}, volume={9}, number={10}, pages={ziaf132}}"}}, {"_id": "37537006", "pmid": 37537006, "title": "Implementation and assessment of a novel drug interaction tool (TLC-act) in an entry-to-practice doctor of pharmacy program.", "journal": "Curr Pharm Teach Learn", "authors": ["Dahri K", "Hong C", "Yang C", "Chan F"], "date": "2023-08-01T00:00:00Z", "doi": "10.1016/j.cptl.2023.07.018", "meta_date_publication": "2023 Aug 1", "meta_volume": "", "meta_issue": "", "meta_pages": "", "score": 50244.586, "text_hl": "Students were instructed to view all five videos and then complete a patient case that focused on the @<m>DISEASE_Ototoxicity</m> @DISEASE_MESH:D000081015 @@@DDI@@@ between @CHEMICAL_Ciprofloxacin @CHEMICAL_MESH:D002939 @@@ciprofloxacin@@@ and @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@. ", "citations": {"NLM": "Dahri K, Hong C, Yang C, Chan F. Implementation and assessment of a novel drug interaction tool (TLC-act) in an entry-to-practice doctor of pharmacy program. Curr Pharm Teach Learn. 2023 Aug 1;():. PMID: 37537006", "BibTeX": "@article{37537006, title={Implementation and assessment of a novel drug interaction tool (TLC-act) in an entry-to-practice doctor of pharmacy program.}, author={Dahri K and Hong C and Yang C and Chan F}, journal={Curr Pharm Teach Learn}}"}}, {"_id": "40963686", "pmid": 40963686, "title": "Successful rescue of a rare case of refractory shock due to multidrug toxicity: a case report.", "journal": "Front Pharmacol", "authors": ["Xie Y", "Zhou Y", "Cao Y"], "date": "2025-09-02T00:00:00Z", "doi": "10.3389/fphar.2025.1669831", "meta_date_publication": "2025", "meta_volume": "16", "meta_issue": "", "meta_pages": "1669831", "score": 50237.754, "text_hl": "Conclusion: The treatment of mixed @<m>DISEASE_Ototoxicity</m> @DISEASE_MESH:D000081015 @@@drug poisoning@@@ involving @CHEMICAL_Reserpine @CHEMICAL_MESH:D012110 @@@reserpine@@@, @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@, and @CHEMICAL_Enalapril @CHEMICAL_MESH:D004656 @@@enalapril@@@ is very challenging. ", "citations": {"NLM": "Xie Y, Zhou Y, Cao Y. Successful rescue of a rare case of refractory shock due to multidrug toxicity: a case report. Front Pharmacol. 2025;16():1669831. PMID: 40963686", "BibTeX": "@article{40963686, title={Successful rescue of a rare case of refractory shock due to multidrug toxicity: a case report.}, author={Xie Y and Zhou Y and Cao Y}, journal={Front Pharmacol}, volume={16}, pages={1669831}}"}}, {"_id": "35132603", "pmid": 35132603, "title": "Cytokine Storm and Failed Resolution in COVID-19: Taking a Cue from Multiple Sclerosis.", "journal": "Adv Exp Med Biol", "authors": ["Zahoor I", "Li Y", "Rattan R", "Giri S"], "date": "2021-01-01T00:00:00Z", "doi": "10.1007/978-3-030-85109-5_13", "meta_date_publication": "2021", "meta_volume": "1352", "meta_issue": "", "meta_pages": "211-222", "score": 50237.656, "text_hl": "Also, reports suggest a better outcome in @DISEASE_Diabetes_Mellitus @DISEASE_MESH:D003920 @@@diabetic@@@ @SPECIES_9606 @@@patients@@@ with reasonable glycemic control, which certainly hints towards a hidden role of anti-@<m>DISEASE_Ototoxicity</m> @DISEASE_MESH:D000081015 @@@hyperglycemic drugs@@@ such as @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ in alleviating disease pathology through its anti-@DISEASE_Inflammation @DISEASE_MESH:D007249 @@@inflammatory@@@ feature. ", "citations": {"NLM": "Zahoor I, Li Y, Rattan R, Giri S. Cytokine Storm and Failed Resolution in COVID-19: Taking a Cue from Multiple Sclerosis. Adv Exp Med Biol. 2021;1352():211-222. PMID: 35132603", "BibTeX": "@article{35132603, title={Cytokine Storm and Failed Resolution in COVID-19: Taking a Cue from Multiple Sclerosis.}, author={Zahoor I and Li Y and Rattan R and Giri S}, journal={Adv Exp Med Biol}, volume={1352}, pages={211-222}}"}}, {"_id": "30173896", "pmid": 30173896, "title": "[Drug-induced vasculitis].", "journal": "Therapie", "authors": ["Fathallah N", "Ouni B", "Mokni S", "Baccouche K", "Atig A", "Ghariani N", "Azzabi A", "Denguezli M", "Slim R", "Ben Salem C"], "date": "2019-06-01T00:00:00Z", "doi": "10.1016/j.therap.2018.07.005", "meta_date_publication": "2019 Jun", "meta_volume": "74", "meta_issue": "3", "meta_pages": "347-354", "score": 50066.574, "text_hl": "[@<m>DISEASE_Ototoxicity</m> @DISEASE_MESH:D000081015 @@@Drug-induced vasculitis@@@].", "citations": {"NLM": "Fathallah N, Ouni B, Mokni S, Baccouche K, Atig A, Ghariani N, Azzabi A, Denguezli M, Slim R, Ben Salem C. [Drug-induced vasculitis]. Therapie. 2019 Jun;74(3):347-354. PMID: 30173896", "BibTeX": "@article{30173896, title={[Drug-induced vasculitis].}, author={Fathallah N and Ouni B and Mokni S and Baccouche K and Atig A and Ghariani N and Azzabi A and Denguezli M and Slim R and Ben Salem C}, journal={Therapie}, volume={74}, number={3}, pages={347-354}}"}}]}